Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mattia De Nuzzo"'
Autor:
Giulia Pasello, Aline S. C. Fabricio, Paola Del Bianco, Valentina Salizzato, Adolfo Favaretto, Luisa Piccin, Fable Zustovich, Alessio Fabozzi, Costanza De Rossi, Jacopo Pigozzo, Mattia De Nuzzo, Elia Cappelletto, Laura Bonanno, Dario Palleschi, Gian Luca De Salvo, Valentina Guarneri, Massimo Gion, Vanna Chiarion-Sileni
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Immune Checkpoint Inhibitors (ICIs) lead to durable response and a significant increase in long-term survival in patients with advanced malignant melanoma (MM) and Non-Small Cell Lung Cancer (NSCLC). The identification of serum cy
Externí odkaz:
https://doaj.org/article/eaa29a66434e4108acd2e04152a4052d
Autor:
Giulia Pasello, Alberto Pavan, Mattia De Nuzzo, Stefano Frega, Alessandra Ferro, Alessandro Dal Maso, Laura Bonanno, Valentina Guarneri, Fabio Girardi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRandomized clinical trials (RCTs) represent the mainstay for the approval of new treatments. However, stringent inclusion criteria often cause them to depart from the daily clinical practice. Real-world (RW) evidence have a complementing
Externí odkaz:
https://doaj.org/article/c1ca128ba78b4aa2be51fa68df6d3251
Autor:
Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, Alberto Pavan, Loc Carlo Bao, Mattia De Nuzzo, Stefano Frega, Giulia Sartori, Alessandra Ferro, Giulia Pasello, Paolo Morandi, Giuseppe Aprile, Valentina Guarneri
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundRecent clinical trials demonstrated longer survival in extended small cell lung cancer (SCLC) patients treated with immunotherapy in addition to chemotherapy. However, the magnitude of benefit is modest and the impact in real-world setting
Externí odkaz:
https://doaj.org/article/ebb6c0a9fefe486f86d7906a97795967